Mkts

Ultragenyx Pharmaceutical Inc.

NASDAQ: RARE
$16.08-0.19 (-1.17%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
15.8516.32
52-week range
12.7339.89
Today
Open16.30
Previous close16.08
Volume—
Valuation
Market cap1.66B
P/E ratio—
EPS (TTM)-5.19
Income & risk
Dividend / yield—
Beta0.30
Avg volume3.76M
Discussion

RARE News

Stories mentioning RARE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue136,000207,571159,933166,496139,000164,647139,494147,026
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development187,000203,052216,212164,736166,000187,901170,109161,503
Sales General & Admin88,00088,73486,62086,64687,00081,88580,35180,604
Total Operating Expenses
Operating Income (Loss)(169,000)(113,222)(170,890)(107,888)(143,000)(122,305)(131,987)(116,361)
Interest Income6,0006,3435,8635,7947,00010,04410,7317,401
Interest Expense
Other Expense(934.00)(1,043)2,140837.00(4,643)3,077(1,829)
Pretax Income(184,000)(127,456)(179,540)(114,004)(150,000)(132,818)(133,213)(130,740)
Tax Provision1,0001,180873.00947.001,000384.00303.00858.00
Net Income (Loss)(185,000)(128,636)(180,413)(114,951)(151,000)(133,202)(133,516)(131,598)
Earnings Per Share (Basic)(1.84)(1.30)(1.81)(1.17)(1.57)(1.47)(1.40)(1.52)
Earnings Per Share (Diluted)(1.84)(1.30)(1.81)(1.17)(1.57)(1.47)(1.40)(1.52)
Weighted Average Shares Outstanding (Basic)100,60098,60099,77198,46096,30090,50095,49486,581
Weighted Average Shares Outstanding (Diluted)100,60098,60099,77198,46096,30090,50095,49486,581

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RARE

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is a stock listed on the Nasdaq Stock Market under the ticker symbol RARE. It last traded at $16.08 (Nov 13, 2026, 4:00 PM ET), down 1.2% on the day. That gives Ultragenyx Pharmaceutical a market capitalisation of $1.7B.

Over the past 52 weeks RARE has traded between $12.73 and $39.89.

Revenue for the quarter ended Mar 31, 2026 was $136.0M; a net loss of $185.0M. Revenue was down 2.2% from $139.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$136.0M-$185.0M-136.0%
Dec 31, 2025$207.6M-$128.6M-62.0%
Sep 30, 2025$159.9M-$180.4M-112.8%
Jun 30, 2025$166.5M-$115.0M-69.0%

From Ultragenyx Pharmaceutical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…